HEXO Corp. (HEXO)
(Delayed Data from AMEX)
$7.73 USD
+0.27 (3.62%)
Updated May 3, 2019 04:00 PM ET
After-Market: $7.72 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.73 USD
+0.27 (3.62%)
Updated May 3, 2019 04:00 PM ET
After-Market: $7.72 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Are Marijuana Stocks, ETFs Poised for Upbeat Earnings?
by Sanghamitra Saha
"Essential Business" status tagged with marijuana selling amid lockdowns should have helped cannabis stocks and ETFs in the first quarter.
Molson Coors Unveils Movo, To Explore Colorado's CBD Space
by Zacks Equity Research
Molson Coors (TAP) launches Movo, a new line of canned wine spritzers, in the United States. It also forms a JV with HEXO to explore opportunities for CBD-infused beverages in Colorado.
Are Options Traders Betting on a Big Move in HEXO Stock?
by Nilanjan Gupta
Investors need to pay close attention to HEXO stock based on the movements in the options market lately.
Earnings Preview: HEXO (HEXO) Q2 Earnings Expected to Decline
by Zacks Equity Research
HEXO (HEXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What Do Canopy Earnings Say About Cannabis ETFs?
by Sanghamitra Saha
Solid earnings drive Canopy Growth stock and boost the industry as a result. Is it right time to buy marijuana ETFs?
Implied Volatility Surging for HEXO Stock Options
by Zacks Equity Research
Investors need to pay close attention to HEXO stock based on the movements in the options market lately.
What's Ahead for Marijuana ETFs After a Dismal Show in 2019?
by Sanghamitra Saha
Marijuana ETFs hit a high in 2018 only to experience a bloodbath in 2019. Let's see what lies in store for the space in 2020.
HEXO (HEXO) Flat As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, HEXO (HEXO) closed at $2.19, marking no change from the previous day.
HEXO (HEXO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
HEXO (HEXO) closed the most recent trading day at $2.17, moving +1.88% from the previous trading session.
Is the Options Market Predicting a Spike in HEXO Corp (HEXO) Stock?
by Zacks Equity Research
Investors need to pay close attention to HEXO Corp (HEXO) stock based on the movements in the options market lately.
Can Bill Hopes Relieve Earnings-Induced Pain in Pot ETFs?
by Sanghamitra Saha
A wave of disappointing earnings caused a bloodbath in marijuana ETFs last week. However, talks of an end to the federal embargo on marijuana could turn this segment around.
Marijuana Stocks to Buy or Avoid in November
by Tirthankar Chakraborty
We highlight three marijuana stocks that look like solid bargains, while one in particular should be avoided in the near future.
Implied Volatility Surging for HEXO (HEXO) Stock Options
by Zacks Equity Research
Investors need to pay close attention to HEXO (HEXO) stock based on the movements in the options market lately.
HEXO (HEXO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
HEXO (HEXO) closed the most recent trading day at $3.95, moving -0.04% from the previous trading session.
HEXO (HEXO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
HEXO (HEXO) closed at $4.01 in the latest trading session, marking a +0.75% move from the prior day.
HEXO (HEXO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, HEXO (HEXO) closed at $4.37, marking a -0.91% move from the previous day.
HEXO (HEXO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
HEXO (HEXO) closed at $4.26 in the latest trading session, marking a +1.43% move from the prior day.
HEXO (HEXO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, HEXO (HEXO) closed at $4.91, marking a -1.8% move from the previous day.
Is the Options Market Predicting a Spike in HEXO Corp. (HEXO) Stock?
by Zacks Equity Research
Investors need to pay close attention to HEXO Corp. (HEXO) stock based on the movements in the options market lately.
What's in the Offing for HEXO Corp's (HEXO) Q3 Earnings?
by Zacks Equity Research
HEXO Corp's (HEXO) recent 1,000,000 sq. ft. greenhouse expansion is likely to reflect on quarterly results.
The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Canopy Growth, Aurora Cannabis and Hexo
by Zacks Equity Research
The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Canopy Growth, Aurora Cannabis and Hexo
HEXO (HEXO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
HEXO (HEXO) closed at $6.47 in the latest trading session, marking a +0.78% move from the prior day.
4 CBD Stocks to Win Big in June
by Tirthankar Chakraborty
Analysts estimate that nearly 65 million Americans have tried CBD and 63% have found it effective. What's more, CBD is a growing industry with sales expected to rise 55% to $648 million in 2019.
HEXO (HEXO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
HEXO (HEXO) closed at $6.86 in the latest trading session, marking a -1.86% move from the prior day.
Medtronic (MDT) to Report Q4 Earnings: Will It Top Estimates?
by Zacks Equity Research
We are upbeat about Medtronic's (MDT) successful execution of growth strategies such as therapy innovation, globalization and increase in economic value.